<DOC>
	<DOCNO>NCT00002935</DOCNO>
	<brief_summary>RATIONALE : Photodynamic therapy use light drug make cancer cell sensitive light kill tumor cell . This may effective treatment esophageal cancer . PURPOSE : Phase II trial study effectiveness photodynamic therapy treat patient Barrett 's esophagus situ esophageal cancer .</brief_summary>
	<brief_title>Photodynamic Therapy Treating Patients With Early Esophageal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate efficacy photodynamic therapy ( PDT ) use porfimer sodium ( Photofrin ) control uniform laser light patient carcinoma situ Barrett 's esophagus severe dysplasia Barrett 's esophagus . II . Evaluate safety treatment patient . OUTLINE : This noncomparative study . PDT consist IV porfimer sodium follow 40-50 hour later laser red light deliver optic fiber pass biopsy channel endoscope . Retreatment , necessary , consist 3 injection least 30 day apart 6 laser light treatment , maximum 2 follow injection . Patients follow monthly 4 month , periodically least 5 year . PROJECTED ACCRUAL : A total 20 patient accrue study .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Dihematoporphyrin Ether</mesh_term>
	<mesh_term>Trioxsalen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary , stage 0 carcinoma situ ( CIS ) conjunction Barrett 's esophagus severe dysplasia Barrett 's esophagus medically unsuitable refuse surgery Previously biopsied Barrett 's mucosa area severe dysplasia and/or CIS PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky great 50 % Life expectancy : Not specify Hematopoietic : WBC least 2,000/mm3 Platelet count least 50,000/mm3 Hepatic : No porphyria hypersensitivity porphyrins Bilirubin great 3.0 mg/dL Alkaline phosphatase great 3 time ULN SGOT great 3 time ULN PT great 1.5 time upper limit normal ( ULN ) Renal : Creatinine great 3.0 mg/dL Other : No contraindication endoscopy Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No concurrent chemotherapy At least 1 month since prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No concurrent radiation therapy No concurrent laser therapy At least 1 month since prior radiation therapy At least 1 month since prior laser therapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>stage 0 esophageal cancer</keyword>
</DOC>